Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
-
Publication Venue For
-
Prospective Evaluation of PSMA-Targeted 18F-DCFPyL PET/CT in Men with Biochemical Failure After Radical Prostatectomy for Prostate Cancer.
61:58-61.
2020
-
Diagnostic Accuracy of 18F-FDG PET/CT in Infective Endocarditis and Implantable Cardiac Electronic Device Infection: A Cross-Sectional Study..
57:1726-1732.
2016
-
Vascular targeted radioimmunotherapy for the treatment of glioblastoma.
57:1576-1582.
2016
-
Synthesis and preliminary evaluation of 5-[18F]fluoroleucine: a novel LAT1 substrate.
57.
2016
-
PET lesion quantitation noise estimates from sub-scan images.
55.
2014
-
Exploratory evaluation of MR permeability with 18F-FDG PET mapping in pediatric brain tumors: a report from the Pediatric Brain Tumor Consortium..
54:1237-1243.
2013
-
First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer..
54:380-387.
2013
-
The future of USP monographs for PET drugs.
54:472-475.
2013
-
Association of heat production with 18F-FDG accumulation in murine brown adipose tissue after stress..
52:1616-1620.
2011
-
A high-performance SPECT-CT system for dedicated molecular breast imaging.
52:673-674.
2011
-
SPECT in acute pulmonary embolism..
50:1999-2007.
2009
-
Combination of converging collimators for high-sensitivity brain SPECT..
50:1548-1556.
2009
-
Comparing small lesion PET image quality with count statistics over a range of body sizes.
50.
2009
-
Image quality evaluation on a new time-of-flight PET.
50.
2009
-
Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380..
49:1628-1635.
2008
-
Imaging biomarkers roundtable report.
49:22N-+.
2008
-
Collaborations in the development and validation of imaging biomarkers..
49:36N-37N.
2008
-
Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow..
49:517-523.
2008
-
Recommendations on the use of 18F-FDG PET in oncology..
49:480-508.
2008
-
Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6..
49:30-38.
2008
-
Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380..
48:1492-1500.
2007
-
Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 3: alpha-particle-induced radiolytic effects on the chemical behavior of (211)At..
48:1190-1196.
2007
-
NIH MICAD initiative and guest author program opportunities..
48:19N.
2007
-
Commentary.
48.
2007
-
PET/CT in cancer patient management. Commentary..
48 Suppl 1:1S.
2007
-
On-axis sensitivity and resolution of a slit-slat collimator..
47:1884-1890.
2006
-
Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer..
47:1607-1611.
2006
-
Targeted alpha-particle therapy of microscopic disease: Providing a further rationale for clinical investigation..
47:1238-1240.
2006
-
Integrating PET and CT information to improve diagnostic accuracy for lung nodules: A semiautomatic computer-aided method..
47:1075-1080.
2006
-
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials..
47:1059-1066.
2006
-
Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone)..
47:989-998.
2006
-
Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results..
47:912-918.
2006
-
Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with alpha-, beta-, and auger electron-emitting radionuclides..
47:1007-1015.
2006
-
Radiopharmaceutical chemistry of targeted radiotherapeutics, Part 2: radiolytic effects of 211At alpha-particles influence N-succinimidyl 3-211AT-astatobenzoate synthesis..
46:1393-1400.
2005
-
Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study..
46:1042-1051.
2005
-
Radiopharmaceutical chemistry of targeted radiotherapeutics, part 1: effects of solvent on the degradation of radiohalogenation precursors by 211At alpha-particles..
46:700-706.
2005
-
Problems created in attenuation-corrected SPECT images by artifacts in attenuation maps: a simulation study..
46:335-343.
2005
-
Current status of therapy of solid tumors: brain tumor therapy..
46 Suppl 1:151S-156S.
2005
-
Prediction of death and nonfatal myocardial infarction in high-risk patients: a comparison between the Duke treadmill score, peak exercise radionuclide angiography, and SPECT perfusion imaging..
46:5-11.
2005
-
The additive value of combined assessment of myocardial perfusion and ventricular function studies..
45:1721-1724.
2004
-
PET tracers for osteosarcoma..
45:1424.
2004
-
Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V..
45:108-115.
2004
-
In vitro cytotoxicity of (211)at-astatide and (131)I-iodide to glioma tumor cells expressing the sodium/iodide symporter..
44:1827-1838.
2003
-
Initial X-ray design considerations for application specific emission and transmission tomography (ASETT) of the breast..
44:287P-287P.
2003
-
Microdosimetric analysis of alpha-particle-emitting targeted radiotherapeutics using histological images..
44:792-805.
2003
-
Mammotomography with pinhole incomplete circular orbit SPECT..
44:583-593.
2003
-
Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients..
44:134-139.
2003
-
Feasibility of application specific emission & transmission tomography (ASETT) of the breast..
43:12P-12P.
2002
-
Negatively charged substituent-bearing acylation agent for the radiohalogenation of mAbs..
43:366P-366P.
2002
-
Radioimmunotherapy of refractory non-Hodgkin's lymphoma with I-131-labeled chimeric 81C6 anti-tenascin monoclonal antibody: Dosimetry study..
43:313P-313P.
2002
-
Receiver operating characteristic evaluation of triple-head 360 degree versus dual-head 180 degree myocardial SPECT acquisition..
43:53P-53P.
2002
-
Single and double knife-edge pinhole collimators for SPECT imaging of small volumes..
43:223P-224P.
2002
-
Synthesis and in vitro evaluation of glycated octreotate conjugates labeled with radioiodine and At-211 via a tin precursor..
43:92P-92P.
2002
-
Myocardial contractile reserve and perfusion defect severity with rest and stress dobutamine (99m)Tc-sestamibi SPECT in canine stunning and subendocardial infarction..
43:540-550.
2002
-
Pharmacokinetics and radiation dosimetry of 18F-fluorocholine..
43:92-96.
2002
-
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers..
42:1805-1814.
2001
-
High-level production of alpha-particle-emitting (211)At and preparation of (211)At-labeled antibodies for clinical use..
42:1508-1515.
2001
-
Incremental prognostic value of RNA ejection fraction measurements during pharmacologic stress testing: a comparison with clinical and perfusion variables..
42:871-877.
2001
-
Analytic determination of pinhole collimator sensitivity with penetration..
42:140P-140P.
2001
-
Characteristics of a rotating gamma camera with 1-inch sodium iodide detectors for SPECT and PET..
42:98P-98P.
2001
-
Dedicated PICO-SPECT: An approach to clinical breast imaging..
42:207P-208P.
2001
-
Dedicated breast imaging with an ASET: Application specific emission tomograph..
42:97P-97P.
2001
-
Dynamic Cardiac Beating Heart Phantom..
42:165P-165P.
2001
-
Modeling respiratory motion in the superquadric-based cardiac-thorax phantom..
42:141P-141P.
2001
-
Radioimmunotherapy of recurrent glioma patients using alpha-particle emitting astatine-211 labeled chimeric anti-tenascin monoclonal antibody..
42:121P-122P.
2001
-
FDG PET imaging in patients with pathologically verified dementia..
41:1920-1928.
2000
-
Myocardial hibernation and stunning: still much to learn..
41:1235-1236.
2000
-
Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects..
41:1134-1138.
2000
-
Cardiac SPECT attenuation correction using an integrated x-ray CT/dual-head scintillation camera system..
41:22P-22P.
2000
-
Effects of reconstruction methods and attenuation correction on hot bladder artifacts in PET..
41:194P-194P.
2000
-
Microdosimetry of alpha-particle-emitting At-211-labelled monoclonal antibody (MAb) using histological images of malignant brain tumors..
41:84P-84P.
2000
-
V-48 biodistribution and radiation dosimetry using V-48 PET imaging..
41:238P-239P.
2000
-
Transmission scanning system for a gamma camera coincidence scanner..
41:692-699.
2000
-
Receiver operating characteristic evaluation of iterative reconstruction with attenuation correction in 99mTc-sestamibi myocardial SPECT images..
41:502-513.
2000
-
211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation..
40:1197-1203.
1999
-
Small-animal PET: advent of a new era of PET research..
40:1176-1179.
1999
-
Comparison of diagnostic performance in brain PET imaging using 3D and 2D acquisition modes..
40:118P-118P.
1999
-
Design and performance of a self-shielded CS-137 multiple-point-source transmission scanning system for rotating gamma camera..
40:34P-34P.
1999
-
Effect and correction of detector sag in SPECT systems..
40:285P-285P.
1999
-
High-resolution in vivo SPECT imaging of I-131 biodistributions using a rotating parallel-hole collimator..
40:34P-35P.
1999
-
Regional FDG uptake, attenuation, and geometries measurements for whole body phantom design..
40:281P-281P.
1999
-
Ultra-high resolution SPECT images with uranium pinhole collimators..
40:34P-34P.
1999
-
Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors..
40:631-638.
1999
-
Coincidence imaging with a dual-head scintillation camera..
40:432-441.
1999
-
Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency)..
40:239-243.
1999
-
Locally increased uptake of fluorine-18fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors.
39:1376-1380.
1998
-
Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors..
39:1376-1380.
1998
-
Transmission imaging for nonuniform attenuation correction using a three-headed SPECT camera..
39:1105-1110.
1998
-
A PC-based patient-specific external dose calculation method for outpatient I-131 therapy..
39:277P-277P.
1998
-
A comparison of OSEM and ICD for iterative reconstruction of SPECT brain images..
39:79P-79P.
1998
-
Composite quadric-based object model for SPECT Monte Carlo simulation..
39:121P-121P.
1998
-
Detection of recurrent brain tumor: Comparison of MR registered camera-based (CB) and dedicated (D) PET images..
39:257P-257P.
1998
-
Human IgG(2) constant region enhances the in vivo stability of monoclonal antibody 81C6 compared to its murine parent..
39:77P-77P.
1998
-
Lesion detection using nonattenuation corrected dedicated and camera-based PET compared with attenuation corrected dedicated PET..
39:109P-109P.
1998
-
Minimizing cardiac motion blurring and improving image signal-to-background using gated SPECT and statistically based 3D morphological deformations..
39:121P-121P.
1998
-
Myocardial kinetics of meta-[I-131]iodobenzylguanidine in an adriamycin cardiomyopathy rat model..
39:47P-47P.
1998
-
N.C.A. 5-Iodo-1(2-deoxy,2-fluoro-beta-D-arabinofuranosyl)uracil (FIAU): Tissue uptake in D-54 glioma xenograft mouse model and cytotoxicity to D-247 glioma cells in vitro..
39:104P-105P.
1998
-
Positron imaging of pulmonary nodules: Phantom study..
39:108P-108P.
1998
-
Pre-clinical SPECT studies to evaluate [I-123]HEPIE as a lung cancer imaging agent..
39:227P-227P.
1998
-
Pretargeted radioimmunotherapy using anti-tenascin 81C6-streptavidin conjugates and radiolabeled biotin: Preparation of reagents..
39:105P-106P.
1998
-
Quantitative imaging of iodine-131 distributions in brain tumors with pinhole SPECT: a phantom study..
39:856-864.
1998
-
Transmission scanning on a gamma camera coincidence imaging system..
39:92P-93P.
1998
-
Iodine-131-metaiodobenzylguanidine uptake in metastatic carcinoid tumor to the orbit..
39:647-650.
1998
-
Effect of registration errors between transmission and emission scans on a SPECT system using sequential scanning..
39:365-373.
1998
-
Prognosis by measurements of left ventricular function during exercise.
39:140-146.
1998
-
Prognosis by measurements of left ventricular function during exercise. Duke Noninvasive Research Working Group..
39:140-146.
1998
-
Camera-based PET: the best is yet to come..
38:1796-1797.
1997
-
Right and left ventricular volume and ejection fraction by tomographic gated blood-pool scintigraphy..
38:942-948.
1997
-
A method for labeling internalizing antibodies with astatine-211..
38:15-15.
1997
-
A novel dual detector probe for gamma-ray guided intraoperative beta imaging..
38:21-21.
1997
-
Anatomical variations affecting cardiac imaging in female patients: A phantom study..
38:64-64.
1997
-
Breast cancer detection using vertical axis-of-rotation (VAOR) SPECT with half-cone beam collimation..
38:936-936.
1997
-
Dedicated breast imaging system based on a novel solid state detector array.
38:535-535.
1997
-
Dosimetry methods for patients with malignant CNS tumors treated with I-131 81C6 via surgically created cystic resection cavity..
38:395-395.
1997
-
Effects of collimator septal penetration on 511 keV SPECT images.
38:937-937.
1997
-
Estimating joint posterior distributions for the volumes and activities of small structures in emission tomography..
38:934-934.
1997
-
High resolution brain SPECT imaging using half fan-beam collimators with a right-angle dual-camera SPECT system..
38:113-113.
1997
-
Mechanisms of uptake in isolated rat heart of potential radiotherapeutic agent [At-211]meta-astatobenzylguanidine (MABG)..
38:106-106.
1997
-
Microdosimetry and small-scale dosimetry of At-211 in bone marrow: An analysis based on histological imaging..
38:963-963.
1997
-
Optimal dose division for two-injection, two-condition FDG PET brain studies..
38:470-470.
1997
-
Survival and DNA damage in V79 cells exposed to the alpha emitters 5-[At-211]astato-2'-deoxy-uridine and [At-211]astatide..
38:964-964.
1997
-
Transmission data acquisition apparatus for a three-headed SPECT system..
38:933-933.
1997
-
Transmission data acquisition with a large field-of-view, dual-headed SPECT system..
38:935-935.
1997
-
Use of an analytic model of pinhole aperture penetration for resolution recovery in I-131 pinhole SPECT..
38:210-210.
1997
-
No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog..
38:330-334.
1997
-
Uptake and retention kinetics of para-fluorine-18-fluorobenzylguanidine in isolated rat heart..
37:2011-2016.
1996
-
A method for the radiohalogenation of internalizing antibodies..
37:1825-1825.
1996
-
Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET..
37:1438-1444.
1996
-
A quantitative evaluation of 3D PET in FDG brain imaging..
37:993-993.
1996
-
An economic decision analysis of preoperative risk stratification in 6,489 intermediate risk patients undergoing vascular surgery..
37:45-45.
1996
-
An experimental phantom based on quantitative SPECT analysis of patient MIBI biodistribution.
37:676-676.
1996
-
Characterization and rejection of annihilation gamma-ray background for a surgical beta ray camera that utilizes positron emitting radiopharmaceuticals.
37:303-303.
1996
-
Comparison of subjective image quality of 2D vs 3D acquisition in clinical clinical brain PET..
37:285-285.
1996
-
Correcting for emission contamination in SPECT scanning line source transmission data..
37:65-65.
1996
-
Design of a small scintillation camera with photodiode readout for imaging malignant breast tumors..
37:200-200.
1996
-
Effect of breast size and shape on defect contrast in myocardial perfusion SPECT imaging..
37:980-980.
1996
-
Effects of specific activity on uptake and retention of metaiodobenzylguanidine (MIBG) in the heart: Revisited.
37:701-701.
1996
-
Feasibility of pinhole fluorine-18 SPECT of the brain: A Monte Carlo study..
37:469-469.
1996
-
Fluorine-18 labeling of [Nle(4),D-Phe(7)]-alpha-MSH, an alpha-melanocyte stimulating hormone (alpha-MSH) analogue..
37:875-875.
1996
-
Hemodynamic indices of myocardial dysfunction correlate with dipyridamole thallium-201 SPECT..
37:723-729.
1996
-
Imaging I-131 distributions in brain tumor phantoms with pinhole SPECT..
37:965-965.
1996
-
Impact of image registration on the interpretation of MRI and FDG PET images in patients with known or suspected brain tumors..
37:76-76.
1996
-
Iodine-120-mIBG: Production and NCA labelling of a new PET radiotracer..
37:874-874.
1996
-
Limited-angular-view ML-EM pinhole SPECT for breast tumor detection..
37:971-971.
1996
-
Meta-[At-211]astatobenzylguanidine (MABG): In vivo evaluation in an athymic mouse human neuroblastoma xenograft model..
37:236-236.
1996
-
PET imaging of pheochromocytoma (PHEO) in dogs using PARA [F-18]fluorobenzylguanidine (PFBG)..
37:915-915.
1996
-
Preparation and binding properties of an astatine-211 labeled biotin conjugate..
37:900-900.
1996
-
Quantitative SPECT Thallium indices predict outcomes in Emory angioplasty versus surgery trial (EAST)..
37:491-491.
1996
-
Stress Thallium SPECT is equally effective for predicting outcomes for women and men in the Emory angioplasty versus surgery trial (EAST)..
37:492-492.
1996
-
The relationship of age and maximal oxygen consumption to myocardial blood flow in normal subjects assessed by dipyridamole N-13 ammonia PET..
37:804-804.
1996
-
Half-cone beam collimation for triple-camera SPECT systems..
37:498-502.
1996
-
Localization of technetium-99m-sestamibi in diffuse myelodysplastic processes..
37:471-473.
1996
-
Thallium-201 uptake in lung cancer..
36:1514-1519.
1995
-
Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy..
36:883-887.
1995
-
Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG..
36:644-650.
1995
-
Evaluation of SPECT quantification of radiopharmaceutical distribution in canine myocardium..
36:278-286.
1995
-
Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities..
35:1771-1776.
1994
-
Volume and activity quantitation with iodine-123 SPECT..
35:1707-1713.
1994
-
PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment..
35:1506-1513.
1994
-
Performance characteristics of a whole-body PET scanner..
35:1398-1406.
1994
-
3-DIMENSIONAL PHOTON SCATTER IN NONUNIFORM MEDIA FOR A SIMULATED TC-99M SPECT MYOCARDIAL PERFUSION STUDY.
35:P17-P17.
1994
-
A COMPARISON OF FUNCTIONAL MRI AND H2O-15 PET CHANGES DURING VISUAL-STIMULATION.
35:P32-P32.
1994
-
DYNAMIC FDG-PET IMAGING OF FOCAL PULMONARY ABNORMALITIES TO IDENTIFY OPTIMUM TIME FOR IMAGING.
35:P225-P225.
1994
-
EXTRAPOLATION OF TRUNCATED PROJECTIONS IN FB-TCT - A QUANTITATIVE APPROACH.
35:P33-P33.
1994
-
HEMATOLOGIC TOXICITY RELATED TO I-131 METAIODOBENZYLGUANIDINE THERAPY.
35:P234-P234.
1994
-
INCOMPLETE-DATA TREATMENT OF COMPTON SCATTER IN SPECT.
35:P17-P17.
1994
-
MEASURED DEFECT CONTRAST WITH SIMULTANEOUS TL-201/TC-99M DUAL-ISOTOPE CARDIAC SPECT.
35:P196-P196.
1994
-
MECHANISTIC STUDIES OF METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) UPTAKE AND RETENTION IN ISOLATED RAT-HEART.
35:P57-P57.
1994
-
METABOLIC CHARACTERIZATION OF PEDIATRIC PRIMARY BRAIN-TUMORS USING FDG-PET.
35:P44-P44.
1994
-
ML-EM VS FBP IN CONVERGING BEAM SPECT - COMPARISON OF AXIAL BLURRING ARTIFACTS REDUCTION USING NONZERO ACTIVITY DISK PHANTOMS.
35:P190-P190.
1994
-
MONITORING OF RESPONSE TO NEOADJUVANT THERAPY OF SOFT-TISSUE AND MUSCULOSKELETAL SARCOMAS USING F-18-FDG PET.
35:P38-P38.
1994
-
MULTIPINHOLE COLLIMATION FOR SUPERHIGH RESOLUTION, SMALL FIELD-OF-VIEW SPECT.
35:P27-P27.
1994
-
MYOCARDIAL AND ADRENAL UPTAKE OF PARA [F-18] FLUOROBENZYLGUANIDINE (PFBG) IN THE DOG.
35:P255-P255.
1994
-
PARA[F-18] FLUOROBENZYLGUANIDINE (PFBG) KINETICS IN A CANINE CORONARY-ARTERY OCCLUSION MODEL.
35:P157-P157.
1994
-
QUANTITATIVE IMAGING OF AT-211 RADIOTHERAPEUTIC AGENTS IN SMALL VOLUMES.
35:P180-P180.
1994
-
QUANTITATIVE MEASUREMENTS FOR SMALL ORGANS OF MONKEY.
35:P179-P179.
1994
-
ROC CURVE AND LOGISTIC-REGRESSION ANALYSIS OF VISUAL AND SEMIQUANTITATIVE FDG PET DATA IN THE EVALUATION OF FOCAL PULMONARY ABNORMALITIES.
35:P227-P227.
1994
-
SYNTHESIS AND PRELIMINARY EVALUATION OF 4-[F-18]FLUORO-3-IODOBENZYLGUANIDINE (FIBG) - A METAIODOBENZYLGUANIDINE ANALOG FOR PET.
35:P248-P248.
1994
-
TE-123M FOR DETERMINATION OF ATTENUATION MAP WITH THE EXISTENCE OF TC-99M IN PATIENTS.
35:P195-P195.
1994
-
An evaluation of lesion detectability with cone-beam, fanbeam and parallel-beam collimation in SPECT by continuous ROC study..
35:135-140.
1994
-
Cardiac phantom evaluation of simultaneously acquired dual-isotope rest thallium-201/stress technetium-99m SPECT images..
34:1998-2006.
1993
-
Accuracy of registration of PET, SPECT and MR images of a brain phantom..
34:1587-1594.
1993
-
Fast transmission CT for determining attenuation maps using a collimated line source, rotatable air-copper-lead attenuators and fan-beam collimation..
34:1577-1586.
1993
-
3-DIMENSIONAL BAYESIAN RECONSTRUCTION FOR SPECT.
34:P20-P20.
1993
-
A COMPARISON OF PARALLEL BEAM, FAN BEAM, AND CONE-BEAM COLLIMATORS FOR 3D SPECT BRAIN IMAGING BASED ON MUTUAL INFORMATION CRITERION.
34:P195-P196.
1993
-
A FAST ITERATIVE RECONSTRUCTION ALGORITHM FOR CONE-BEAM SPECT.
34:P80-P80.
1993
-
A NONUNIFORM ATTENUATION CORRECTION FOR QUANTITATIVE THORAX SPECT BASED ON LUNG EMISSION.
34:P190-P190.
1993
-
A POSTRECONSTRUCTION ARTIFICIAL NEURAL-NETWORK FOR COMPENSATION OF COLLIMATOR, ATTENUATION AND SCATTER EFFECTS IN SPECT.
34:P19-P19.
1993
-
A STUDY OF RESOLUTION AND SENSITIVITY FOR PARALLEL AND CONE-BEAM COLLIMATORS.
34:P80-P80.
1993
-
AN EVALUATION OF LESION DETECTABILITY WITH CONE-BEAM, FAN BEAM AND PARALLEL BEAM COLLIMATION IN SPECT BY CONTINUOUS ROC ANALYSIS.
34:P81-P81.
1993
-
DIFFERENTIATION OF BENIGN AND MALIGNANT PULMONARY OPACITIES WITH FDG-PET.
34:P21-P21.
1993
-
EFFECT OF INDEX OF REFRACTION ON DETECTOR ELEMENT IDENTIFICATION IN PET BLOCK DETECTORS.
34:P180-P180.
1993
-
EVALUATION OF SPECT QUANTIFICATION USING INVIVO DOG STUDIES AND TC-99M LABELED MAA.
34:P26-P26.
1993
-
GENERALIZED DUAL-ENERGY WINDOW SCATTER COMPENSATION FOR SPECT.
34:P72-P72.
1993
-
IMAGING OSTEOSARCOMA IN DOGS USING F-18 LABELED TP-3 MONOCLONAL-ANTIBODY (MAB) FRAGMENT AND PET.
34:P216-P216.
1993
-
INVITRO CYTOTOXICITY OF M-[AT-211]ASTATOBENZYLGUANIDINE (MABG).
34:P218-P218.
1993
-
LABELING MONOCLONAL-ANTIBODIES (MABS) WITH AT-211 USING N-SUCCINIMIDYL 5-[AT-211]ASTATO-3-PYRIDINECARBOXYLATE (SAPC).
34:P99-P100.
1993
-
MEASURING ASTATINE-211 DISTRIBUTIONS WITH SPECT.
34:P191-P191.
1993
-
NONUNIFORM ATTENUATION COMPENSATION FOR TC-99M CARDIAC SPECT USING ACQUIRED TRANSMISSION DATA.
34:P30-P30.
1993
-
PARA[F-18]FLUOROBENZYLGUANIDINE (PFBG) - A POTENTIAL TRACER FOR IMAGING HEART AND TUMOR USING PET.
34:P79-P79.
1993
-
PERFORMANCE-CHARACTERISTICS OF A NEW-GENERATION PET SCANNER.
34:P101-P101.
1993
-
PINHOLE COLLIMATION FOR ULTRA-HIGH-RESOLUTION, SMALL-FIELD-OF-VIEW SPECT STUDIES.
34:P10-P10.
1993
-
POST IRRADIATION C-13 AND H-2 NMR ANALYSIS OF AQUEOUS ETHANOL AND ACETIC-ACID SOLUTIONS FOR INSITU [N-13] AMMONIA PRODUCTION.
34:P239-P240.
1993
-
THE PREDICTIVE IMPORTANCE OF FDG-PET IN PATIENTS WITH TEMPORAL-LOBE SEIZURES.
34:P23-P23.
1993
-
FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS..
34:567-575.
1993
-
Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy..
34:39-47.
1993
-
Determination of extent and location of coronary artery disease in patients without prior myocardial infarction by thallium-201 tomography with pharmacologic stress..
33:2067-2073.
1992
-
Technetium-99m-N1-(2-mercapto-2-methylpropyl)-N2-(2-propargylthio-2- methylpropyl)-1,2-benzenediamine (T691): preclinical studies of a potential new tracer of regional cerebral perfusion..
33:1836-1842.
1992
-
Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography..
33:1535-1541.
1992
-
STANDARDIZED TESTS OF PET PERFORMANCE - REPLY.
33:1430-1431.
1992
-
Standardized tests of PET performance..
33:1429-1431.
1992
-
Fluorine-18-antimyosin monoclonal antibody fragments: preliminary investigations in a canine myocardial infarct model..
33:575-580.
1992
-
Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography..
33:532-536.
1992
-
An evaluation of maximum likelihood-expectation maximization reconstruction for SPECT by ROC analysis..
33:451-457.
1992
-
Synthesis, rodent biodistribution, dosimetry, metabolism, and monkey images of carbon-11-labeled (+)-2 alpha-tropanyl benzilate: a central muscarinic receptor imaging agent..
33:423-430.
1992
-
Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum..
33:345-350.
1992
-
The current role of SPECT in imaging subdural hematoma..
33:248-250.
1992
-
Metastatic angiosarcoma with thrombocytopenia and intratumoral indium-111-platelet deposition..
32:2278-2280.
1991
-
Performance standards in positron emission tomography..
32:2342-2350.
1991
-
Comparison of bicycle and treadmill radionuclide angiocardiography..
32:1918-1922.
1991
-
The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers..
32:1518-1525.
1991
-
Treatment of Compton scattering in maximum-likelihood, expectation-maximization reconstructions of SPECT images..
32:1285-1291.
1991
-
Clinical application of PET for the evaluation of brain tumors..
32:616-622.
1991
-
Quantitative SPECT reconstruction of iodine-123 data..
32:527-533.
1991
-
Defective parallel-hole collimator encountered in SPECT: a suggested approach to avoid potential problems..
31:1892-1893.
1990
-
Radionuclide angiocardiography revisited..
31:1300-1302.
1990
-
Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow..
31:1183-1190.
1990
-
Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: comparison of one- and two-day protocols in normal volunteers..
31:1128-1132.
1990
-
Internally administered isotopes in the treatment of solid malignancy..
31:601-602.
1990
-
Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging..
31:526-534.
1990
-
Editorial: Radionuclide angiocardiography revisited.
31:1300-1302.
1990
-
Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT..
31:61-66.
1990
-
Clinical PET: Study scheduling and coordination.
30.
1989
-
Technetium-99m labeled NR-LU-10 monoclonal antibody (MoAb) in assessing patients with carcinoma of the lung.
30.
1989
-
Utility of FDG-PET in the evaluation of seizures and primary brain tumors.
30.
1989
-
SPECT - CURRENT STATUS OF INSTRUMENTATION AND DATE PROCESSING.
29:2026-2026.
1988
-
A new method to determine left ventricular pressure-volume loops in the clinical setting..
29:1492-1497.
1988
-
SPECT using a specially designed cone beam collimator..
29:1398-1405.
1988
-
Nonisotropic attenuation in SPECT: phantom tests of quantitative effects and compensation techniques..
28:1584-1591.
1987
-
Inverse Monte Carlo as a unified reconstruction algorithm for ECT..
27:1577-1585.
1986
-
Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine..
27:1138-1142.
1986
-
3-(2'-[F-18]FLUOROETHYL)SPIPERONE - TOMOGRAPHIC DOPAMINE RECEPTOR CHARACTERIZATION IN LIVING PRIMATES.
27:879-879.
1986
-
CONE-BEAM SPECT - EXPERIMENTAL VALIDATION USING A CONVENTIONALLY-DESIGNED CONVERGING COLLIMATOR.
27:930-930.
1986
-
EXPERIMENTALLY-MEASURED SCATTER FRACTIONS AS A QUANTITATIVE TEST OF MONTE-CARLO SIMULATIONS.
27:960-960.
1986
-
INVERSE MONTE-CARLO IMAGE-RECONSTRUCTION FOR SPECT WITH MAXIMUM-LIKELIHOOD-ESTIMATION.
27:895-895.
1986
-
Utilization of lung scans by clinicians..
27:366-369.
1986
-
Factors affecting ventricular volumes determined by a count-based equilibrium method..
26:1042-1047.
1985
-
Research and clinical potential of receptor based radiopharmaceuticals..
26:655-662.
1985
-
Deconvolution of Compton scatter in SPECT..
26:403-408.
1985
-
CORRECTION METHODS AND FACTORS FOR DOSE CALIBRATOR ASSAY OF I-123.
26:P101-P101.
1985
-
ELECTROPHILIC FLUORINATIONS WITH GLYCALS - EFFECT OF SOLVENT AND SUBSTRATE ON PRODUCT DISTRIBUTION.
26:P125-P125.
1985
-
F-18 LABELED 3-FLUORODIAZEPAM.
26:P38-P38.
1985
-
HIGH-RESOLUTION MRI IMAGING AT 1.5T USING SURFACE COILS.
26:P8-P8.
1985
-
Phosphorus-32 therapy of cystic Grade IV astrocytomas: Technique and preliminary application.
26:1335-1338.
1985
-
STEREOSPECIFIC APPROACH TO THE SYNTHESIS OF [F-18]2-DEOXY-2-FLUORO-D-MANNOSE.
26:P127-P127.
1985
-
Effects of characteristic x-rays on assay of I-123 by dose calibrator..
25:1367-1370.
1984
-
The synthesis of 2-[F-18]fluoro-2-deoxy-D-glucose using glycals: a reexamination..
25:1327-1334.
1984
-
A gamma camera for medical applications, using a multiwire proportional counter..
25:1003-1012.
1984
-
Improved SPECT quantification using compensation for scattered photons..
25:893-900.
1984
-
Disproportionate effects of regional hypokinesis on radionuclide ejection fraction: compensation using attenuation-corrected ventricular volumes..
25:747-754.
1984
-
Bone and liver images in medullary carcinoma of the thyroid gland: concise communication..
25:419-422.
1984
-
(F-18)N-FLUORO-N-ALKYLSULFONAMIDES - NOVEL REAGENTS FOR RADIOFLUORINATION.
25:P23-P23.
1984
-
ATTENUATION COEFFICIENTS FOR TC-99M PHOTONS IN WATERFILLED PHANTOMS, DETERMINED WITH A GAMMA-CAMERA - VARIATION WITH ENERGY WINDOW.
25:P22-P23.
1984
-
ENZYMATIC-SYNTHESIS OF (N-13) OR (C-11) CARBAMYL-PHOSPHATE AND THEIR USE FOR LABELING METABOLITES OF THE UREA CYCLE AND THE PYRIMIDINE NUCLEOTIDE PATHWAY.
25:P64-P64.
1984
-
EVALUATION OF SPECT SYSTEM PERFORMANCE BY QUANTATATIVELY COMPARING PLANAR AND RECONSTRUCTED SPATIAL RESOLUTIONS.
25:P107-P108.
1984
-
FLUORINATION IN AQUEOUS-MEDIA WITH ELEMENTAL FLUORINE - THE SYNTHESIS OF [F-18] 2-FDG.
25:P125-P125.
1984
-
MONTE-CARLO EVALUATION OF COMPTON SCATTER COMPENSATION BY DEONVOLUTION IN SPECT.
25:P71-P71.
1984
-
THE ESTIMATION OF SPECT STATISTICAL RELIABILITY.
25:P70-P70.
1984
-
VARIATIONS IN ATTENUATION COEFFICIENTS FOR TC-99M PHOTONS WITH SOURCE DEPTH AND REGION-OF-INTEREST SIZE.
25:P23-P23.
1984
-
Tl-201 single-photon emission computed tomography (SPECT).
24:273-275.
1983
-
THE SUBTRACTION OF SCATTERED EVENTS FROM SPECT PHOTOPEAK EVENTS.
24:P82-P82.
1983
-
TI-201 SINGLE-PHOTON EMISSION COMPUTED-TOMOGRAPHY (SPECT) - REPLY.
24:273-274.
1983
-
Reflux of radiopharmaceutical into the inferior vena cava during first-transit studies of the heart..
23:1141.
1982
-
Comparison of 180 degrees and 360 degrees data collection in thallium-20 1 imaging using single-photon emission computerized tomography (SPECT): concise communication..
23:655-660.
1982
-
Imaging of brain tumors after administration of L-(N-13)glutamate: concise communication..
23:682-687.
1982
-
Imaging with Tc-99m MDP and Ga-67 citrate in patients with rheumatoid arthritis and suspected septic arthritis: concise communication..
23:479-482.
1982
-
In vivo regional quantitation of intrathoracic Tc-99m using SPECT: concise communication..
23:446-450.
1982
-
Studying regional brain function: a challenge for SPECT..
23:266-270.
1982
-
Human platelets labeled with In-111 8-hydroxyquinoline: kinetics, distribution, and estimates of radiation dose..
23:149-156.
1982
-
Lesion detection with single-photon emission computed tomography (SPECT) compared with conventional imaging..
23:97-102.
1982
-
DIAGNOSIS OF ALCOHOLIC CIRRHOSIS WITH THE RIGHT-TO-LEFT HEPATIC LOBE RATIO - CONCISE COMMUNICATION.
23:80-80.
1982
-
Improved diagnosis of renal osteodystrophia by the use of Tc-99m MDP bone clearance.
23.
1982
-
PRODUCTION ALTERNATIVES IN OXYGEN IMAGING.
23:P107-P108.
1982
-
Re:diagnosis of alcoholic cirrhosis with the right-to-left hepatic lobe ratio: concise communication..
23:80.
1982
-
SPATIAL LINEARITY REQUIREMENTS FOR ROTATING GAMMA-CAMERA SPECT.
23:P45-P45.
1982
-
THE EFFECT OF SOURCE MOTION ON LESION CONTRAST WITH SPECT AND CONVENTIONAL IMAGING.
23:P44-P45.
1982
-
Accuracy of left ventricular end-diastolic dimension determinations obtained by radionuclide angiocardiography..
22:500-505.
1981
-
LESION DETECTABILITY OF ROTATING CAMERA-BASED SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY (SPECT).
22:P39-P39.
1981
-
SYNTHESIS OF N-13 LABELED MONOCARBOXYLIC AMINO-ACIDS, SUITABLE FOR PATIENT STUDIES, WITH IMMOBILIZED GLUTAMATE-DEHYDROGENASE.
22:P74-P75.
1981
-
THALLIUM STUDIES USING SINGLE PHOTON-EMISSION COMPUTED-TOMOGRAPHY (SPECT).
22:P11-P11.
1981
-
Effects of isometric handgrip and dynamic exercise on left-ventricular function..
21:1131-1138.
1980
-
Imaging of the human heart after administration of L-(N-13)glutamate..
21:988-991.
1980
-
Correction for field nonuniformity in scintillation cameras through removal of spastial distortion..
21:771-776.
1980
-
The effect of target-gas purity on the chemical form of F-18 during 18F-F2 production using the neon/fluorine target..
21:758-762.
1980
-
Site of Tc-99m binding to the red blood cell: concise communication..
21:676-678.
1980
-
BREMSSTRAHLUNG IMAGING OF INTRAPERITONEAL P-32 DISTRIBUTIONS.
21:P33-P33.
1980
-
COUNT-RATE LIMITATIONS OF ANGER SCINTILLATION CAMERAS.
21:P81-P81.
1980
-
LEFT-VENTRICULAR VOLUME USING ATTENUATION-CORRECTED MULTIGATED DATA.
21:P50-P50.
1980
-
A new container geometry for better sensitivity in radiometric measurements..
20:1090-1092.
1979
-
Quantitative scanning of osteogenic sarcoma with nitrogen-13-labeled L-glutamate..
20:782-784.
1979
-
Concentration of Tc-99m methylenediphosphonate in hepatic metastases from squamous cell carcinoma..
20:303-305.
1979
-
ORGAN IMAGING WITH L-GLUTAMATE-N-13.
20:663-663.
1979
-
SPATIAL DISTORTION CORRECTION METHOD FOR GAMMA-CAMERAS.
20:608-608.
1979
-
Nitrogen-13 nitrous oxide for cerebral imaging studies.
19:700.
1978
-
Radionuclide emission computed tomography of the head with 99mCc and a scintillation camera..
18:373-380.
1977
-
TC-99M PYROPHOSPHATE DETECTION OF PERIOPERATIVE MYOCARDIAL-INFARCTION IN CARDIAC-SURGERY PATIENTS.
17:524-524.
1976
-
Species differences in myocardial localization of N 13 labeled amino acids.
16:529.
1975
-
Evaluation of 133Xe techniques for measurement of regional ventilation..
15:598-604.
1974
-
Increased resolving power from scintillation cameras using electronic signal processing and a movable filter plate..
14:14-20.
1973
-
Definition of nuclear medicine..
9:465.
1968
-
A multifaceted approach to quantifying pulmonary physiology. The autofluoroscope..
8:342-343.
1967
-
Elementary radiation dosimetry..
8:370.
1967
-
Inferring the causality network of Abeta and Tau accumulation in the aging brain: a statistical inference approach
2017
-
IN VIVO MEASURE OF CARDIAC EFFICIENCY USING HYBRID PET/MRI TECHNOLOGY
2019
-
PSMA-targeted alpha therapeutic agent with fast kidney clearance
2019
-
The Prognostic Impact of Dual FDG/Somatostatin Receptor PET in Metastatic Neuroendocrine Tumours: Updated Overall Survival from the NFTPFT Study
2019
-
F-18-labeling of an anti-HER2 sdAb with a renal brush border enzyme-cleavable linker-containing prosthetic agent via a trans-cyclooctene (TCO)-terazine (Tz) inverse electron-demand Diels-Alder reaction (IEDDAR) for reduced renal uptake
2018
-
Sensitivity of various FDG PET-CT SUV thresholds for round atelectasis
2018
-
Simplified At-211-labeling of internalizing proteins by preconjugation with the tin precursor of a residualizing prosthetic agent: Application to an anti-HER2 single domain antibody fragment
2018
-
Small Molecule Radiohalogenated (I-125/At-211), DOTA Containing PSMA Inhibitors: Metal Complexation and Competing Inhibitor Improve Biodistribution in Mice
2018
-
Feasibility of 124I anti-PD-L1 PET/CT imaging in a syngeneic tumor model of breast cancer.
2017
-
Labeling an anti-HER2 VHH with F-18 using a residualizing prosthetic group via strain-promoted click reaction: preliminary evaluation
2017
-
211At-Labeled Small-Molecule PSMA Inhibitors: Effect of Structure on Biodistribution in Mice
2016
-
Comparison of Q.Clear (regularized) reconstruction versus OS-EM for characterization of small lesions in oncologic PET/CT
2016
-
Dual 18F-fluorodeoxyglucose/68Gallium DOTATATE (FDG/DOTA) PET grading and histological grade in neuroendocrine tumours (NET)
2016
-
Improved survival in 211 patients with stage IV carcinoid tumor treated with high dose I-131 MIBG is predicted by response at initial follow up and by multiple rounds of I-131 MIBG.
2016
-
SPECT/CT Imaging of Prostatic PSMA Expression with Tc99m trofolastat chloride in Healthy Volunteers
2016
-
[211At]YC-I-27 for PSMA-Targeted Alpha-Particle Radiopharmaceutical Therapy
2016
-
A At-211-labeled nanobody for alpha-particle therapy of HER2-expressing cancers
2015
-
Preclinical development of Meta-[At-211]astatobenzylguanidine ([At-211]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma (NB).
2015
-
PET lesion quantitation noise estimates from sub-scan images
2014
-
Prognostic value of CZT SPECT camera in cardiac imaging
2014
-
Radioiodinated AGI-5198 for in vivo imaging of isocitrate dehydrogenase 1 (IDH1) mutation in gliomas
2014
-
Validity of two-day lymphoscintigraphy for detection of lymphatic basins
2014
-
Patient-specific model of NaF PET to facilitate multicenter clinical trial PET imaging protocols and analysis: preliminary results of a CT-based simulation
2013
-
Translocator protein (TSPO) as an imaging target in pancreatic cancer
2013
-
Iodoquine as a potential PET radiolabel for in vivo cell trafficking of leukocyte tumor cell lines
2012
-
Modular nanotransporters: A flexible platform forward for targeted Auger electron therapy
2012
-
A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[18F]pentafluoropropyl)-acetamide([18F]EF5)
2011
-
An alternative and expedient synthesis of radioiodinated 4-iodophenylalanine
2011
-
A novel X-ray-visible microencapsuled mesenchymal stem cell therapy for peripheral arterial disease
2010
-
Burn induced changes in spinal cord and diaphragm glucose metabolism in rodents
2010
-
Disruption of Functional Brain Connections in Alzheimer's Disease
2010
-
VirtualDose: A CT dose reporting software based on anatomically realistic phantoms
2010
-
A comparative study of procedure times for pharmacologic studies in myocardial perfusion imaging
2009
-
An astatine-211 labeled PSMA inhibitor for targeted alpha-particle radiotherapy of prostate carcinoma
2009
-
Radiation dose estimates of [123I] and [131I] iodoquine, putative radiotracers targeting cells with high ALDH expression
2009
-
Characterization of Discovery ST and advance PET systems using a whole-body phantom.
2003
-
Convection enhanced delivery of TP-38 immunotoxin for the therapy of brain tumors: Assessment of delivery and distribution by means of registered SPECT and MRI.
2003
-
Impact of partial volume correction on small malignant lung nodules.
2003
-
The effects of mechanical and electronic shifts on pinhole SPECT resolution.
2003
-
Impact of CT fusion on camera-based PET (CBPET) for clinical oncology applications.
2001
-
Efficiency comparison between Tc-99m tetrofosmin and Tc-99m sestamibi myocardial perfusion studies.
2000
-
[F-18]fluorocholine (FCH) as an oncologic PET tracer: Evaluation in murine prostate cancer xenograft model.
2000
-
Comparison of rest and physical exercise stress F-18 FDG myocardial PET studies in patients with diminished left ventricular ejection fraction.
1998
-
Estimation of perfusion and oxygen utilization rate in tumors with PET: A technique without arterial blood sampling.
1998